These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21593568

  • 1. Preanalytical sample handling and sample stability testing for the neurochemical dementia diagnostics.
    Zimmermann R, Lelental N, Ganslandt O, Maler JM, Kornhuber J, Lewczuk P.
    J Alzheimers Dis; 2011; 25(4):739-45. PubMed ID: 21593568
    [Abstract] [Full Text] [Related]

  • 2. Assessment of Preanalytical Cerebrospinal Fluid Handling and Storage Factors on Measurement of Aβ1-42, Aβ1-40, and pTau181 Using an Automated Chemiluminescent Platform.
    Ho S, Darrow J, De Simone F, Calabro A, Gannon S, Esquivel R, Thakker P, Khingelova K, Rao A, Zhang Y, Moghekar A.
    J Appl Lab Med; 2024 Jul 01; 9(4):789-802. PubMed ID: 38712812
    [Abstract] [Full Text] [Related]

  • 3. Influence of delayed CSF storage on concentrations of phospho-tau protein (181), total tau protein and beta-amyloid (1-42).
    Kaiser E, Schönknecht P, Thomann PA, Hunt A, Schröder J.
    Neurosci Lett; 2007 May 01; 417(2):193-5. PubMed ID: 17408854
    [Abstract] [Full Text] [Related]

  • 4. Bacterial contamination and the transport vial material affect cerebrospinal fluid concentrations of β-Amyloid and Tau protein as determined by enzyme immunoassay.
    Fronek K, Lange P, Spreer A, Eiffert H, Nau R.
    Dement Geriatr Cogn Disord; 2011 May 01; 32(2):126-34. PubMed ID: 21952521
    [Abstract] [Full Text] [Related]

  • 5. Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.
    Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, Engelborghs S, Mroczko B, Gabryelewicz T, Teunissen C, Mollenhauer B, Parnetti L, Chiasserini D, Molinuevo JL, Perret-Liaudet A, Verbeek MM, Andreasen N, Brosseron F, Bahl JM, Herukka SK, Hausner L, Frölich L, Labonte A, Poirier J, Miller AM, Zilka N, Kovacech B, Urbani A, Suardi S, Oliveira C, Baldeiras I, Dubois B, Rot U, Lehmann S, Skinningsrud A, Betsou F, Wiltfang J, Gkatzima O, Winblad B, Buchfelder M, Kornhuber J, Lewczuk P.
    J Alzheimers Dis; 2016 Mar 01; 52(1):51-64. PubMed ID: 26967210
    [Abstract] [Full Text] [Related]

  • 6. Intrathecal IgG synthesis in patients with alterations in the neurochemical dementia diagnostics.
    Zimmermann R, Beck G, Knispel S, Maler JM, Weih M, Wiltfang J, Kornhuber J, Lewczuk P.
    J Alzheimers Dis; 2010 Mar 01; 19(4):1199-203. PubMed ID: 20308786
    [Abstract] [Full Text] [Related]

  • 7. Pre-analytical factors influencing the stability of cerebrospinal fluid proteins.
    Simonsen AH, Bahl JM, Danborg PB, Lindstrom V, Larsen SO, Grubb A, Heegaard NH, Waldemar G.
    J Neurosci Methods; 2013 May 15; 215(2):234-40. PubMed ID: 23537933
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
    Rosenling T, Slim CL, Christin C, Coulier L, Shi S, Stoop MP, Bosman J, Suits F, Horvatovich PL, Stockhofe-Zurwieden N, Vreeken R, Hankemeier T, van Gool AJ, Luider TM, Bischoff R.
    J Proteome Res; 2009 Dec 15; 8(12):5511-22. PubMed ID: 19845411
    [Abstract] [Full Text] [Related]

  • 10. Added diagnostic value of CSF biomarkers in differential dementia diagnosis.
    Le Bastard N, Martin JJ, Vanmechelen E, Vanderstichele H, De Deyn PP, Engelborghs S.
    Neurobiol Aging; 2010 Nov 15; 31(11):1867-76. PubMed ID: 19150153
    [Abstract] [Full Text] [Related]

  • 11. Preanalytical factors affecting the stability of matrix metalloproteinase-2 concentrations in cerebrospinal fluid.
    Sulik A, Wojtkowska M, Oldak E.
    Clin Chim Acta; 2008 Jun 15; 392(1-2):73-5. PubMed ID: 18373981
    [Abstract] [Full Text] [Related]

  • 12. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J, Senanarong V, Poungvarin N, Chakorn T, Siwasariyanon N, Washirutmangkur L, Udompunthuruk S.
    J Med Assoc Thai; 2011 Feb 15; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [Abstract] [Full Text] [Related]

  • 13. Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.
    Wiltfang J, Esselmann H, Bibl M, Hüll M, Hampel H, Kessler H, Frölich L, Schröder J, Peters O, Jessen F, Luckhaus C, Perneczky R, Jahn H, Fiszer M, Maler JM, Zimmermann R, Bruckmoser R, Kornhuber J, Lewczuk P.
    J Neurochem; 2007 May 15; 101(4):1053-9. PubMed ID: 17254013
    [Abstract] [Full Text] [Related]

  • 14. Effects of processing and storage conditions on amyloid beta (1-42) and tau concentrations in cerebrospinal fluid: implications for use in clinical practice.
    Schoonenboom NS, Mulder C, Vanderstichele H, Van Elk EJ, Kok A, Van Kamp GJ, Scheltens P, Blankenstein MA.
    Clin Chem; 2005 Jan 15; 51(1):189-95. PubMed ID: 15539465
    [Abstract] [Full Text] [Related]

  • 15. Abeta1-42 Detection in CSF of Alzheimer's disease is influenced by temperature: indication of reversible Abeta1-42 aggregation?
    Sancesario GM, Esposito Z, Nuccetelli M, Bernardini S, Sorge R, Martorana A, Federici G, Bernardi G, Sancesario G.
    Exp Neurol; 2010 Jun 15; 223(2):371-6. PubMed ID: 19664624
    [Abstract] [Full Text] [Related]

  • 16. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
    Fagan AM, Roe CM, Xiong C, Mintun MA, Morris JC, Holtzman DM.
    Arch Neurol; 2007 Mar 15; 64(3):343-9. PubMed ID: 17210801
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?
    Clark CM, Xie S, Chittams J, Ewbank D, Peskind E, Galasko D, Morris JC, McKeel DW, Farlow M, Weitlauf SL, Quinn J, Kaye J, Knopman D, Arai H, Doody RS, DeCarli C, Leight S, Lee VM, Trojanowski JQ.
    Arch Neurol; 2003 Dec 15; 60(12):1696-702. PubMed ID: 14676043
    [Abstract] [Full Text] [Related]

  • 18. Neurochemical dementia diagnostics: State of the art and research perspectives.
    Lewczuk P, Wiltfang J.
    Proteomics; 2008 Mar 15; 8(6):1292-301. PubMed ID: 18271068
    [Abstract] [Full Text] [Related]

  • 19. Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid.
    Gabelle A, Roche S, Gény C, Bennys K, Labauge P, Tholance Y, Quadrio I, Tiers L, Gor B, Chaulet C, Vighetto A, Croisile B, Krolak-Salmon P, Touchon J, Perret-Liaudet A, Lehmann S.
    Brain Res; 2010 Oct 21; 1357():175-83. PubMed ID: 20713025
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia.
    Engelborghs S, De Vreese K, Van de Casteele T, Vanderstichele H, Van Everbroeck B, Cras P, Martin JJ, Vanmechelen E, De Deyn PP.
    Neurobiol Aging; 2008 Aug 21; 29(8):1143-59. PubMed ID: 17428581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.